Education
About Us
Working with TipRanks
Follow Us
Peter Kampian Insider Profile
4 Followers
Peter Kampian, Senior Officer at DionyMed Brands Inc, holds 93.94K shares in DionyMed Brands Inc (Ticker: TSE:DYME). Most recently, Peter Kampian ― shares of DionyMed Brands Inc on ― for an estimated value of ―.
Peter Kampian DionyMed Brands Inc (DYME)Senior Officer
DionyMed Brands Inc (DYME)
Senior Officer
Not Ranked
Peter Kampian has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Peter Kampian does not currently own shares as a corporate insider.
A breakdown of Peter Kampian's holdings
Insider Roles
Peter Kampian does not currently hold a role as a corporate insider.
Roles that Peter Kampian holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Peter Kampian
Peter Kampian's Trading History
List of latest transactions for each holding click on a transaction to see Peter Kampian's performance on stock
You May Also Like
Peter Kampian insider profile FAQ
What is the percentage of profitable transactions made by Peter Kampian?
The percentage of profitable transactions made by Peter Kampian is ―.
What is the average return per transaction made by Peter Kampian?
The average return per transaction made by Peter Kampian is ―.
What stocks does Peter Kampian hold?
Peter Kampian holds: TSE:DYME stocks.
What was Peter Kampian’s latest transaction?
Peter Kampian latest transaction was an Uninformative Buy of ―.
What was Peter Kampian's most profitable transaction?
Peter Kampian’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Peter Kampian's role in DionyMed Brands Inc?
Peter Kampian's role in DionyMed Brands Inc is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.